Ilan Oren - Medigus Executive Officer
| MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Executive
Ilan Oren is Executive Officer of Medigus Ltd ADR
| Phone | 972 73 370 4691 |
| Web | https://www.medigus.com |
Medigus Management Efficiency
The company has return on total asset (ROA) of (0.0663) % which means that it has lost $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3072) %, meaning that it created substantial loss on money invested by shareholders. Medigus' management efficiency ratios could be used to measure how well Medigus manages its routine affairs as well as how well it operates its assets and liabilities.Medigus Ltd ADR currently holds 10.13 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. Medigus Ltd ADR has a current ratio of 1.35, which is within standard range for the sector. Note, when we think about Medigus' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hadar Levy | Brainsway | 50 | |
| Yuliya Aslan | Paragon 28 | N/A | |
| Hillegonda Groen | Brainsway | 55 | |
| David Hoffman | Delcath Systems | N/A | |
| Mark Hooley | Nortech Systems Incorporated | N/A | |
| Andrew Hill | Paragon 28 | 40 | |
| Sandra Pennell | Delcath Systems | 44 | |
| Richard MD | Brainsway | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 64 | |
| Gordon Weber | SurModics | 61 | |
| Matthew Brinckman | Paragon 28 | N/A | |
| Martha Rook | Delcath Systems | 54 | |
| Thomas Stankovich | ReShape Lifesciences | 63 | |
| Carolyn Shelton | Nexalin Technology | 62 | |
| Tlalit TelTzure | Icecure Medical | 53 | |
| Matt Brinckman | Paragon 28 | N/A | |
| Johnny MD | Delcath Systems | 59 | |
| Corey Hancock | Nortech Systems Incorporated | N/A | |
| Michael Nketiah | Nexalin Technology | 48 | |
| Jay Sturm | STRATA Skin Sciences | 68 | |
| Teryl Sides | SurModics | 54 | |
Management Performance
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 |
Medigus Ltd ADR Leadership Team
Elected by the shareholders, the Medigus' board of directors comprises two types of representatives: Medigus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medigus. The board's role is to monitor Medigus' management team and ensure that shareholders' interests are well served. Medigus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medigus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ilan Oren, Executive Officer | ||
| Yaron Silberman, Chief Ltd | ||
| Liron Carmel, Chief Officer | ||
| Tali Dinar, Chief Officer |
Medigus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medigus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.31 | |||
| Return On Asset | -0.0663 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 65.3 M | |||
| Shares Outstanding | 1.89 M | |||
| Shares Owned By Institutions | 0.29 % | |||
| Number Of Shares Shorted | 4.18 K | |||
| Price To Earning | 33.86 X | |||
| Price To Book | 0.15 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |